Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex and racial disparities in catheter ablation.
Vandenberk B, Chew DS, Parkash R, Gillis AM. Vandenberk B, et al. Heart Rhythm O2. 2022 Dec 16;3(6Part B):771-782. doi: 10.1016/j.hroo.2022.08.002. eCollection 2022 Dec. Heart Rhythm O2. 2022. PMID: 36589007 Free PMC article. Review.
Incidence of Torsade de Pointes in a tertiary hospital population.
Vandael E, Vandenberk B, Vandenberghe J, Pincé H, Willems R, Foulon V. Vandael E, et al. Among authors: vandenberk b. Int J Cardiol. 2017 Sep 15;243:511-515. doi: 10.1016/j.ijcard.2017.05.072. Epub 2017 May 19. Int J Cardiol. 2017. PMID: 28576628
Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing.
Engelen MM, Vandenbriele C, Spalart V, Martens CP, Vandenberk B, Sinonquel P, Lorent N, De Munter P, Willems R, Wauters J, Wilmer A, Dauwe D, Gunst J, Guler I, Janssens S, Martinod K, Pieters G, Peerlinck K, Verhamme P, Vanassche T. Engelen MM, et al. Among authors: vandenberk b. Res Pract Thromb Haemost. 2022 Apr 5;6(3):e12683. doi: 10.1002/rth2.12683. eCollection 2022 Mar. Res Pract Thromb Haemost. 2022. PMID: 35415384 Free PMC article.
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens".
Liesenborghs L, Spriet I, Jochmans D, Belmans A, Gyselinck I, Teuwen LA, Ter Horst S, Dreesen E, Geukens T, Engelen MM, Landeloos E, Geldhof V, Ceunen H, Debaveye B, Vandenberk B, Van der Linden L, Jacobs S, Langendries L, Boudewijns R, Dan Do TN, Chiu W, Wang X, Zhang X, Weynand B, Vanassche T, Devos T, Meyfroidt G, Janssens W, Vos R, Vermeersch P, Wauters J, Verbeke G, De Munter P, Kaptein SJF, Rocha-Pereira J, Delang L, Van Wijngaerden E, Neyts J, Verhamme P. Liesenborghs L, et al. Among authors: vandenberk b. EBioMedicine. 2021 Jul;69:103454. doi: 10.1016/j.ebiom.2021.103454. Epub 2021 Jun 26. EBioMedicine. 2021. PMID: 34186486 Free PMC article. No abstract available.
Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy.
Bergau L, Willems R, Sprenkeler DJ, Fischer TH, Flevari P, Hasenfuß G, Katsaras D, Kirova A, Lehnart SE, Lüthje L, Röver C, Seegers J, Sossalla S, Dunnink A, Sritharan R, Tuinenburg AE, Vandenberk B, Vos MA, Wijers SC, Friede T, Zabel M. Bergau L, et al. Among authors: vandenberk b. Int J Cardiol. 2018 Dec 1;272:102-107. doi: 10.1016/j.ijcard.2018.06.103. Epub 2018 Jun 28. Int J Cardiol. 2018. PMID: 29983251 Free article.
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.
Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, Zürn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators. Sticherling C, et al. Among authors: vandenberk b. Europace. 2018 Jun 1;20(6):963-970. doi: 10.1093/europace/eux176. Europace. 2018. PMID: 29016784 Free PMC article.
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project.
Zabel M, Schlögl S, Lubinski A, Svendsen JH, Bauer A, Arbelo E, Brusich S, Conen D, Cygankiewicz I, Dommasch M, Flevari P, Galuszka J, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, Kenttä T, Kucejko T, Haarmann H, Harden M, Iovev S, Kääb S, Kaliska G, Katsimardos A, Kasprzak JD, Qavoq D, Lüthje L, Malik M, Novotný T, Pavlović N, Perge P, Röver C, Schmidt G, Shalganov T, Sritharan R, Svetlosak M, Sallo Z, Szavits-Nossan J, Traykov V, Vandenberk B, Velchev V, Vos MA, Willich SN, Friede T, Willems R, Merkely B, Sticherling C; EU-CERT-ICD Study Investigators. Zabel M, et al. Among authors: vandenberk b. J Electrocardiol. 2019 Nov-Dec;57S:S34-S39. doi: 10.1016/j.jelectrocard.2019.09.001. Epub 2019 Sep 4. J Electrocardiol. 2019. PMID: 31526572 Review.
114 results